Skip Navigation

Overview

The PGY2 Infectious Diseases residency at CMC is an ASHP-accredited 52-week residency program designed to train residents to become independent clinicians and practice leaders in infectious diseases pharmacotherapy.  Through the completion of diverse learning experiences, the resident will develop skills in direct patient care, clinical leadership, research, teaching, precepting, and policy management.  The residency program is customized to reflect the resident’s clinical interests and career goals.

 

Required Block Learning Experiences

Introductory Core Learning Experiences (will be completed prior to other learning experiences whenever feasible) 

  • Orientation (2 to 4 weeks)
  • Adult Antimicrobial Stewardship I (4 to 6 weeks)
  • Infectious Diseases Consults I (4 to 5 weeks)
  • Clinical Microbiology Laboratory (2 to 4 weeks)

Capstone Learning Experiences (will be completed at or near the end of the residency year)

  • Adult Antimicrobial Stewardship II (4 to 5 weeks)
  • Infectious Diseases Consults II (4 to 5 weeks)

Other Required Learning Experiences (can be completed at any time during the residency year)

  • HIV Clinic Experience (4 to 5 weeks)
  • Immunocompromised Infectious Diseases (4 to 5 weeks, note either solid organ transplant or hematologic malignancy/stem cell transplant are pre-requisites, may be completed as a PGY1)

 

Required Longitudinal Learning Experiences   

  • Medication Policy Management (3 months)
  • Clinical Staffing (11 months, every 3rd weekend)
  • Medication Use Evaluation (6 months)
  • Research (12 months)
  • Teaching and Education (12 months) 
  • Longitudinal Inpatient HIV (49 weeks)
  • Treatment Guideline/Protocol Development (6 months) 
  • Quality & Practice Management (12 months, with a concentrated 4 to 5 week block)

 

Elective Learning Experiences (Select 4)

Infectious Diseases Electives

  • Bone and Joint Infections (2 weeks)
  • Infection Prevention (2 weeks)
  • Pediatric Infectious Diseases (4 to 5 weeks)

Other Electives

  • Hematologic Malignancy and Stem Cell Transplant Inpatient (4 to 5 weeks)
  • Medical Intensive Care Unit (4 to 5 weeks)*
  • Solid Organ Transplant (4 to 5 weeks)
  • Surgical/Trauma Intensive Care Unit (4 to 5 weeks) 

*Required if not completed as a PGY1 resident 

Additional electives, including pediatric-specific electives and the opportunity to obtain a teaching certificate, may be available based on resident interest and preceptor availability

Close